Biosimilar Awareness Initiative Reference Group

The Biosimilar Awareness Initiative Reference Group (the Reference Group) was established to give guidance on the activities of the Biosimilar Awareness Initiative and ensure key messages are clearly articulated and appropriately targeted.

Page last updated: 12 July 2018

The Reference Group consists of representatives from a range of groups, including consumers, healthcare professionals, pharmaceutical industry and healthcare education providers.

The Reference Group had its inaugural meeting in Canberra on 07 April 2016

The second meeting of the Reference Group was held in Canberra on 12 May 2016

The third meeting of the Reference Group was held in Canberra on 18 August 2016

The fourth meeting of the Reference Group was held in Canberra on 29 November 2016

A copy of Dr Paul Cornes’s presentation is available upon request by emailing the Quality Use of Medicines Section.

The fifth meeting of the Reference Group was held in Canberra on 11 August 2017

A copy of the TGA Presentation on the evidential basis of marketing approval for biosimilars is available upon request by emailing the Quality Use of Medicines Section.

The sixth meeting of the Reference Group was held in Canberra on 11 May 2018

A copy of Dr Ward's Presentation is available upon request by emailing the Quality Use of Medicines Section.

In this section